<DOC>
	<DOCNO>NCT00346489</DOCNO>
	<brief_summary>A clinical trial establish long term response use intraoperative 5-fluorouracil ( 5-FU ) versus mitomycin C ( MMC ) trabeculectomy glaucoma surgery . Antiproliferative agent 5-fluorouracil Mitomycin C use extensively trabeculectomy surgery improve success surgery prevent visual loss blindness glaucoma patient .</brief_summary>
	<brief_title>Outcomes Intraoperative 5-Fluorouracil Versus Mitomycin C</brief_title>
	<detailed_description>Glaucoma life-long progressive disease , patient live longer . Therefore , long term full evaluation efficacy intraoperative 5-FU MMC need perform assess true efficacy MMC compare 5-FU . We , therefore propose , long-term prospective study patient previously enrol prospective study involve evaluation single intraoperative application mitomycin C versus 5-fluorouracil low moderate risk glaucoma patient .</detailed_description>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>Only patient deem successful 36 month include . These patient participate randomized prospective study trial compare intraoperative 5FU mitomycin C primary trabeculectomy . Only patient deem successful 36 month include . These patient participate randomized prospective study trial compare intraoperative 5FU mitomycin C primary trabeculectomy .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Trabeculectomy</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>Mitomycin C</keyword>
</DOC>